Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Patenting RNA Interference Technology

Related Content

How To Reduce the Risk of Copyright Infringement When Using Generative AI To Write Code

Unlocking AI’s Power to Multiply Manufacturing Productivity

White House Unveils Landmark Executive Order on Safe, Secure, and Trustworthy Artificial Intelligence

Coding with AI in an Open-Source World

What’s in a Name? Why Your “Dual Class” IPO Should Be a “Dual Series” IPO Instead

SEC’s ATS Re-proposal Doubles Down on DeFi and Digital Asset Regulation

Big Deal: What’s New in Tech M&A?

DOJ Announces Safe Harbor Policy for M&A Self-Disclosures

The British Legal Awards Name Goodwin Editor’s Choice Law Firm of the Year

Scottish Equity Partners invests in Braincube

Goodwin Advises GoMetro On £9 million Series A Financing Round

Relay Raises $10M in Seed Funding

Goodwin Advises OQC In UK’s Largest Ever Quantum Computing Series B Round

Leading Capital Markets Partner David Lynn Joins Goodwin to Chair Public Company Advisory Practice

Goodwin Welcomes SEC Alum Lynn to Lead Public Companies Team (Bloomberg Law)

Goodwin Strengthens Public Company Practice with New Hire (BNN)

Technology

Life Sciences